Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Por um escritor misterioso
Descrição
Cancer in the Midst of COVID-19, A Report
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Covid-19 Vaccines — Immunity, Variants, Boosters
Frontiers COVID-19 vaccination in patients with cancer: Opportunities and challenges
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis - eBioMedicine
Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study - eClinicalMedicine
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis - ScienceDirect
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases, Inflammation and Regeneration
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines - Sette - 2022 - Immunological Reviews - Wiley Online Library
Peptides for Vaccine Development
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
de
por adulto (o preço varia de acordo com o tamanho do grupo)
